Participant in Serum Institute's Covid vaccine trial seeks Rs 5 crore compensation

The legal notice to SII says the participant suffered a serious adverse event after being administered the under-trial vaccine, and is demanding financial compensation of Rs 5 crore. The legal notice also alleges that despite this, no public disclosure was made.

Source: The Economic Times - November 28, 2020 Category: Consumer Health News Source Type: news